News

Biogen Inc. (NASDAQ:BIIB) is one of the best S&P 500 stocks with huge upside potential. As of June 16, Biogen emerged as a ...
The company’s unique campaign for a rare, terminal illness nabbed millions of views and a spot on the main stage at the ...
As the saying goes, “If you don’t laugh, you’ll cry.” Biogen and ad agency 21Grams took that mantra to heart with their Gold ...
One notable campaign, developed with ad agency 21Grams, is a dark comedy web series titled “Friedreich’s Back.” This nine-episode series humorously depicts Nikolaus Friedreich, the ...
One notable campaign, developed with ad agency 21Grams, is a dark comedy web series titled “Friedreich’s Back.” This nine-episode series humorously depicts Nikolaus Friedreich, the ...
Friedreich’s Back is a darkly funny campaign that reimagines 19th-century scientist Nikolaus Friedreich rising from the grave to make sense of a world where a treatment now exists for the ...
Biogen's "Friedreich's Back" Takes Top Honors in Pharma; 21GRAMS Named No. 2 Healthcare Agency and Real Chemistry Ranked No. 2 Healthcare Network Globally on Creative Community's Biggest Stage Real ...
So far, Friedreich’s Back has, as the name suggests, brought Friedreich back. The focal point of the Biogen effort is a nine-part video series on social media featuring a quirky scenario in which ...
With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...
The 1860s was an interesting time in the development of clinical and anatomical knowledge, particularly that relating to degenerative diseases. In 1863, Nikolaus Friedreich described progressive ...
Friedreich's Ataxia Market Report Metrics . Details . Study Period. 2020–2034. Coverage. 7MM [The United States, the EU4 (Germany, France, Italy, and Spain) and The United Kingdom, and Japan].